March 5, 2015 8:13 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
(NASDAQ: CLDN) shares gained 11.45% to $21.90 in the pre-market trading session. Roth Capital initiated coverage on Celladon with a Buy rating.
Roundy's, Inc. (NYSE: RNDY) shares rose 10.95% to $4.46 in pre-market trading after the company reported stronger-than-expected results for the fourth quarter.
Pharmacyclics Inc. (NASDAQ: PCYC) shares surged 9.87% to $253.22 in pre-market trading after AbbVie (NYSE: ABBV) announced its plans to acquire Pharmacyclics for $261.25 per share in cash and stock.
Navidea Biopharmaceuticals, Inc (NYSE: NAVB) shares climbed 9.82% to $1.79 in pre-market trading on Q4 results. Navidea Biopharmaceuticals reported a Q3 loss of $0.08 per share on revenue of $2.2 million.
Arrowhead Research Corp. (NASDAQ: ARWR) gained 9.19% to $8.20 in pre-market trading after the company reported the acquisition of Novartis' entire RNAi research and development portfolio and associated assets.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.